Dermal Fillers Market Size to Register USD 8 75 Billion Globally, by 2030, at 9 10% CAGR Growth | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
South Korean consortium to produce Russia s Sputnik Light vaccine Toggle share menu
Advertisement
South Korean consortium to produce Russia s Sputnik Light vaccine
A medical worker fills a syringe with the Sputnik V COVID-19 vaccine at a clinic in the city of Rostov-On-Don, Russia, Dec 22, 2020. (File photo: REUTERS/Sergey Pivovarov)
28 Jun 2021 10:50AM (Updated:
28 Jun 2021 10:50AM) Share this content
Bookmark
SEOUL: Huons Global Co said on Monday (Jun 28) its South Korean consortium plans to begin production of a single-dose Sputnik Light COVID-19 vaccine from as early as September.
The plan followed a request by the Russian Direct Investment Fund (RDIF), which markets the vaccine, and production would take place along with Sputnik V vaccines the consortium also intended to make for the sovereign wealth fund, Huons said.
Share this article
Share this article
NEW YORK, April 14, 2021 /PRNewswire/ Aquavit Holdings LLC announced today that it acquired an exclusive license to register, market and commercialize a botulinum toxin (DTX-021) in the United States and Canada.
For several years, Aquavit has been investing in its proprietary delivery technologies and related intellectual property for botulinum toxin and recently proved its efficacy and safety through a clinical study. It also compared and evaluated optimal dosing with three FDA approved botulinum toxins with varying injection depths and widths.
According to a published article by American Society for Dermatologic Surgery (ASDS), the licensed asset DTX-021 showed equivalency on glabellar lines and improvement on periorbital rhytids compared to onabotulinumtoxinA (BOTOX®) in a multicenter, double-blind, randomized, parallel, active-controlled phase III clinical trial. There were no adverse events.
Aquavit to Introduce A New Botulinum Toxin (DTX-021) prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.